Home
Mintz
Thomas H. Wintner
Thomas H. Wintner
Mintz
Do Patent Claims To Methods Of Treatment Cover In Vivo Transformations?
03 May 2024 | United States
Federal Circuit Affirms Obviousness Of Rifaximin Polymorph Patents And Denial Of Motion To Modify Judgment After Post-Trial Patented Indication Carve Out
01 May 2024 | United States
Trade Secret Litigation Soars In The Life Sciences Industry
03 Oct 2023 | United States
Federal Circuit Puts The Onus On Patent Owners To Disclaim Patent Term Or Face Double-Patenting
08 Sep 2023 | United States
DoJ Filing In Moderna Patent Case Poses Immunity Questions
28 Feb 2023 | United States
N.D. Ill. Finds That A Foreign Parent Corp. May Be Sued Under BPCIA Without The U.S. Subsidiary That Signed And Filed ABLA
22 Sep 2021 | United States
Genus Claims: Foiled Again By Written Description
17 Sep 2021 | United States
COVID-19 Tuition And Fees Lawsuits: Defending University Practices And Defeating Class Claims
29 Jun 2020 | United States
Federal Circuit Affirms Safe Harbor Ruling And $70 Million Award In Amgen Inc. v. Hospira, Inc.
15 Jun 2020 | United States
New Revised USMCA Trade Deal Affects Intellectual Property Rights, But Not Exclusivity Period For Biologics
11 Jun 2020 | United States
Federal Circuit Upholds Application Of Dedication-Disclosure Doctrine At The Pleading Stage
21 May 2020 | United States
Assertion Of Patents Results In Loss Of Sovereign Immunity For Public Universities
29 Dec 2017 | United States
Federal Circuit Rules That BPCIA Preempts State Law Biosimilars Claims
20 Dec 2017 | United States
Federal Circuit Evaluates Import Of Factual Statements Made During BPCIA Pre-Litigation Patent Dance
20 Nov 2017 | United States
Amgen v. Sandoz The Supreme Courts First Biosimilars Ruling
30 Jun 2017 | United States
Amgen Sues Coherus Under BPCIA After Completing Patent Dance
23 May 2017 | United States
Amgen v. Sandoz: The Supreme Court's First Tussle With The BPCIA
04 May 2017 | United States
Amgen v. Sandoz: The Supreme Court’s First Tussle With The BPCIA
04 May 2017 | United States
Janssen v. Celltrion, Damages: "Patent Dance" May Determine Availability Of Lost Profits
06 Apr 2017 | United States
BPCIA Helps Amgen Gain Dismissal Of Genentech Complaint
28 Mar 2017 | United States
< 1 2 >
Contact Details
Boston
Email Website
Boston
United States

  © Mondaq® Ltd 1994 - 2024. All Rights Reserved.